Core Viewpoint - The article discusses the comprehensive interaction between cancer and the human body, emphasizing that cancer is not merely a localized tumor but a systemic disease that hijacks the nervous, immune, and metabolic systems to create a favorable environment for its progression [6]. Group 1: Tumor Microenvironment (TME) - The review highlights the role of the peripheral nervous system (PNS) in regulating metabolic processes and immune cell functions within the TME [4]. - Sympathetic nerves accelerate tumor growth by releasing norepinephrine, which enhances glycolysis and angiogenesis while suppressing CD8+ T cells, creating an immunosuppressive environment [9]. - Sensory nerves, particularly pain-sensing neurons, can both signal the presence of tumors and be exploited by tumors to suppress immune responses through the release of CGRP [10]. - The role of the parasympathetic nervous system remains complex, with evidence suggesting both pro-cancer and potential anti-cancer effects, influencing immune cell functions [12]. Group 2: Tumor Macroenvironment (TMaE) - The article explains how tumors can hijack the brain's metabolic centers, leading to cachexia in late-stage patients, characterized by severe weight loss and fatigue due to the tumor's influence on appetite and metabolism [20]. - Tumors can activate or inhibit neurons in the hypothalamus, which serves as a central regulator of immune responses, indicating that tumors can control the body's immune "master switch" [21][22]. Group 3: Future Therapeutic Strategies - The article suggests new therapeutic approaches, including the use of beta-blockers to disrupt sympathetic signaling and CGRP receptor antagonists to alleviate cancer pain while inhibiting tumor growth [26]. - Precision neuro-modulation techniques, such as selective nerve ablation or advanced genetic and optical methods, are proposed as promising future directions [26]. - A comprehensive treatment strategy is recommended, focusing on both attacking the tumor and repairing the hijacked nervous, immune, and metabolic networks, treating the tumor-host interaction as an integrated ecosystem [26].

Core Insights - The article emphasizes the risks associated with overusing pain relief medications for migraine sufferers, potentially leading to medication overuse headache (MOH) [1][2][3] - It highlights the importance of timely treatment for migraines and the dangers of both under-treatment and over-treatment [2][3] Group 1: Migraine and Its Implications - Migraine is characterized by recurrent, often unilateral, moderate to severe pulsating headaches, accompanied by symptoms such as nausea and sensitivity to light and sound [2] - The condition can lead to various comorbidities, including sleep disorders, anxiety, and depression, and significantly increases the risk of cardiovascular diseases, with studies showing a 1.73 times higher risk of stroke [2][3] Group 2: Medication Overuse Headache (MOH) - MOH occurs when patients experience worsening headaches due to excessive use of acute pain relief medications, which can lead to a vicious cycle of increased headache frequency and severity [2][3] - A clear warning sign for potential MOH is using non-steroidal anti-inflammatory drugs (NSAIDs) more than 15 days a month or triptans over 10 days a month [2][3] Group 3: Healthcare Initiatives and Solutions - In China, approximately 130 million migraine patients exist, with only 52.9% seeking medical attention, indicating a significant gap in treatment [4] - The establishment of headache centers and a national headache prevention network aims to improve diagnosis and treatment, with 740 centers already set up across 30 provinces [4] - The "MOH Zero Project" initiated by the Chinese People's Liberation Army General Hospital aims to reduce the risk of MOH through a comprehensive approach to screening, diagnosis, and treatment [4][5]